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Objective: The postoperative course of cyanotic children is generally more compli-
cated than that of acyanotic children. A possible reason is reoxygenation injury at
the beginning of cardiopulmonary bypass. In this study we tested the hypothesis that
reoxygenation of chronically hypoxic hearts is worse than that of normoxic hearts.
Methods: Two groups of rats (n  9 each) were exposed to either room air (fraction
of inspired oxygen, 0.21%) or chronic hypoxia (fraction of inspired oxygen, 0.10%)
for 2 weeks. Hearts were then isolated and perfused for 30 minutes with hypoxic
buffer (oxygen saturation, 10%), followed by 30 minutes of reoxygenation (oxygen
saturation, 100%).
Results: In hypoxic rats hematocrit values, hemoglobin concentrations, and red cells
were higher (69%  6% vs 40%  6%, 219  14 vs 124  12 g/L, and 10.30 
0.6 vs 6.32  0.5/L/1000, respectively; P  .0001); the amount of ingested food
was less (22.3  4.8 vs 30.7  3.9 g/d, P  .001), as was the amount of ingested
water (21.0  3.1 vs 50.4  14.6 mL/d, P  .0001); and body weight was lower
(182  14.2 vs 351  40.1 g, P  .0001), as was heart weight (1107  119 vs
1312  128 mg, P  .005). The heart weight/body weight ratio was higher (6.10 
0.8 vs 3.74  0.1 mg/g, P  .0001). Systolic and diastolic functions, not different
during the hypoxic baseline period, were more impaired in hypoxic than in nor-
moxic hearts after the reoxygenation, whereas coronary resistance remained lower.
During the hypoxic perfusion, the venous partial pressure of oxygen remained low
in both groups, whereas during reoxygenation, partial pressure of oxygen was higher
in hypoxic hearts, with a lower (P  .01) oxygen uptake. During hypoxic baseline
adenosine triphosphate turnover, lactate production and lactate turnover were lower
in hypoxic hearts (P  .005, P  .0001, and P  .0001, respectively).
Conclusions: Body and blood values are severely affected by chronic hypoxia, and
the cardiac effects of uncontrolled reoxygenation after chronic hypoxia are more
severe than after acute hypoxia.
The progress in the perioperative management of pediatric patientswith congenital heart defects has had a substantial effect on theoutcome of surgical intervention, and a decreased mortality has beenreported also for repair of complex congenital heart defects.1,2 Nev-ertheless, there is a subset of children undergoing cardiac surgerywith higher risk for either a prolonged or complicated postoperative
course: cyanotic patients with preoperative exposure to chronic hypoxia.3,4
Many experimental studies have been performed to evaluate the effects of
hypoxia on the cardiovascular system, but most of them, including our own,
concerned exposure to acute hypoxia.5-7 Because it is evident that hypoxia produces
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long-term effects that could profoundly influence the myo-
cardial metabolism and function,3,8-12 we need studies with
chronic hypoxia.
Currently, there are no models available that adequately
mimic chronic perfusion of hearts with hypoxic blood. A
common experimental model to evaluate the complex ef-
fects of chronic hypoxia on the cardiovascular system is
raising animals in hypoxic or hypobaric chambers for ex-
tended periods of time, killing the animals, excising the
hearts, and perfusing the hearts with oxygenated media. In
this context, however, there are at least 2 instances in which
the hearts may be suddenly reoxygenated prematurely,
thereby undergoing reoxygenation injury.13-16 First, the
classic design of the hypoxic or hypobaric chamber usually
does not allow for daily maintenance, and therefore during
feeding, as well as during cleaning, the animals are exposed
to room air, with subsequent intermittent reoxygenation.
Second, the hearts are generally perfused with oxygenated
media to obtain baseline values; this operation implies that
reoxygenation injury occurs before the baseline hypoxic
values are taken.
In our previous experimental studies with acute hypoxia
we demonstrated that (1) the reoxygenation of hypoxic
hearts impairs the ventricular function significantly more
than after ischemia-reperfusion6 and (2) the reoxygenation-
reperfusion injury is much more severe in hypoxic than in
ischemic hearts.16 The results of our experimental studies
were in agreement with the clinical observation that cya-
notic patients with congenital heart defects are less tolerant
to ischemia with respect to noncyanotic control subjects.17
In this experimental research we used a newly designed
hypoxic chamber system, preventing any premature acci-
dental exposure to room air and hypoxic perfusion during
the initial period. The myocardial metabolism and function
were monitored during the first oxygenation after a 2-week
period of continuous hypoxia. The aim of our study was to
evaluate the systemic and cardiac effects of chronic hypoxia




Male Sprague-Dawley rats (5 weeks old; body weight, 230-250 g
at entry into the protocol) were randomly divided into 2 groups
(n  9 per group): (1) control normoxic animals exposed to room
air (fraction of inspired oxygen [FIO2], 0.21) and (2) chronic
hypoxic animals (FIO2, 0.10). Chronic hypoxic rats were housed in
the normobaric hypoxic chambers described below for 2 weeks.
All animals had free access to water and standard rat chow until 24
hours before the experiment. Water and food consumption was
assessed every 2 days. The investigation conforms to the “Guide
for the Care and Use of Laboratory Animals” published by the
Figure 1. Photograph of the hypoxic chambers used in this study, with the saturimeter showing 10% oxygen
saturation.
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National Institutes of Health (National Institutes of Health Publi-
cation No. 85-23, revised 1996).
Cages
The cages used in this study (Figure 1) were newly designed with
the purpose of fully preventing the animals from experiencing any
accidental exposure to room air (FIO2, 0.21) during their entire
stay, including during feeding and cleaning operations. Transpar-
ent plastics cages (350  350  200 mm) were built for 2 animals
each to accomplish this goal. Every cage was equipped with a
165-mm diameter window with a plastic sleeve (Nufer Medical,
Gumligen, Switzerland). In addition, a hole was made in the cage
to allow for insertion of an oxygen electrode (Servomex Oxygen
Analyzer 570 A, Zurich, Switzerland). An additional precage was
built with the same dimension of the cages but with 2 windows. All
cages were flushed with gas containing 10%  0.1% oxygen
(Carbagas, Lausanne, Switzerland). When a cage opening was
required for regular cleaning and bed change or for operating on
the animal, the precage was first flushed with the hypoxic gas, and
then it was applied on the top of the cage, maintaining the 2
adjacent plastic sleeves. The operator could therefore clean the
cage while avoiding animal exposure to room air. The oxygen
level monitored by means of the oxygen electrode during the
operation never increased by more than 1%. For animal operation,
the animal was first transferred into the precage under hypoxic
conditions, which was then accurately closed and moved to the site
where hearts were perfused. The presence of 2 plastic sleeves
allowed the operator to anesthetize the animal, weigh it, and excise
the heart at the same oxygen level (10%) as that of the animals that
lived inside the precage. The oxygen percentage monitored with
the oxygen electrode during this phase never increased by more
than 2%.
Heart Perfusion
The model of Langendorff perfusion for the isolated heart with
variable oxygen content (Figure 2) has been previously described
in detail.18
Rats were anesthetized with intraperitoneal injection of sodium
thiopental (10 mg/100 g of body weight) and 500 U of heparin.
Immediately after induction of general anesthesia, a blood sample
was collected from the femoral artery for blood gas analysis.
Hearts were rapidly excised and immersed in 0.9% NaCl at room
temperature (25°C). The interval between heart excision and the
beginning of the perfusion was in the 30- to 45-second range.
Hearts were cannulated and immediately perfused with a hypoxic
Krebs-Henseleit buffer containing 2.0 mmol/L free Ca and 11
mmol/L glucose (pH 7.33  0.01) at 37°C. In brief, a roller pump
(Ismatec SA; Labortechnik-Analytik, Glattbrugg-Zurich, Switzer-
land) delivered the medium at a flow of 15 mL/min to an 8-m
pore size, 47-mm diameter filter (MSI, Westboro, Mass), a spe-
cially designed membrane micro-oxygenator (Dideco, Mirandola,
Italy) that flowed with gas at the desired PO2, a preheater, and the
aortic cannula. The coronary flow was maintained constant at 15
mL/min throughout the entire experiment. The gas was provided
from cylinders (Carbagas) containing either 10% oxygen, 6%
carbon dioxide, and 84% nitrogen or 94% oxygen and 6% carbon
dioxide. The nominal accuracy was 0.01%. The temperature of
the heart and of the perfusion medium was maintained at 37°C
with an external water bath. A latex balloon introduced into the left
ventricle was connected to a pressure transducer (MPC-500; Millar
Instruments, Inc, Houston, Tex) to monitor left ventricular perfor-
mance. An additional transducer was inserted above the aortic
cannula to monitor the coronary perfusion pressure. A cannula was
inserted into the pulmonary artery to collect the venous return and
to monitor venous pH, as well as venous PO2, by using an oxygen-
Figure 2. Schema of the Langendorff perfusion for the isolated heart with variable oxygen content.
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sensing electrode (model 5300 Oxygen Monitor; Yellow Springs,
Inc, Yellow Springs, Ohio).
Measurements of Myocardial Function and
Metabolism
Myocardial performance was monitored with a LabView system
(National Instruments, Austin, Tex) running on a personal com-
puter. The measured parameters included left ventricular end-
diastolic pressure (LVEDP), heart rate (HR), left ventricular de-
veloped pressure (LVDP), coronary perfusion pressure (CPP), and
oxygen uptake (VO2), which was calculated from venous PO2 and
coronary flow. The coronary vascular resistance was calculated as
CPP–LVEDP per flow per gram of ventricle. Samples of the
venous effluent were frozen at –80°C and later assayed for lactate
by means of enzymatic methods with COBAS FARA II (Hoffman-
La Roche, Basel, Switzerland) equipment.
Simultaneous measurements of lactate release and venous PO2,
together with glucose as the only substrate, allows estimating the
anaerobic and aerobic contributions to total adenosine triphosphate
(ATP) turnover:
Lactate release  (6  VO2)6
For this, we assumed the ATP/lactate ratio to be 1.0 (glucose as
substrate without significant glycogenolysis) and the ATP/oxygen
ratio to be 6 (no mitochondrial uncoupling).
Experimental Protocol
All hearts were subjected to 30 minutes of hypoxic perfusion with
15 mL/min coronary flow and 10% oxygen saturation. During the
hypoxic period, the intraventricular balloon volume needed to
increase the LVEDP from 0 to 10 mm Hg was measured. The
balloon volume was kept constant throughout the rest of the
experiment. After the hypoxic perfusion, hearts were reoxygenated
for 30 minutes with the perfusion medium at 100% oxygen satu-
ration. At the end of the perfusion, the hearts were weighed.
Statistics
Data are expressed as means  SD.
Results
Animal Homeostasis
Table 1 shows the changes induced by 2 weeks of chronic
hypoxia. Hematocrit values, hemoglobin concentrations,
and red blood cell counts were higher (P  .0001) in
hypoxic than in normoxic rats. The amount of ingested food
was less (P  .001), as was the amount of ingested water
(P  .0001), in hypoxic rats. The body weight was lower
(P  .0001), as was the heart weight (P  .005). The heart
weight/body weight ratio was higher (P  .0001), whereas
the intraventricular balloon volume needed to increase
LVEDP from 0 to 10 mm Hg remained essentially constant
in both groups.
Of course, there was a significant difference between the
2 groups with regard to the arterial PO2 (P  .005) and
oxygen saturation (P  .001).
Myocardial Function
Systolic function. During the hypoxic baseline perfu-
sion, there was no difference between the 2 groups with
regard to HR, LVDP, and HR  LVDP. During reoxygen-
ation, HR and LVDP increased in both groups, but more in
the normoxic group, leading to a significant difference (P
.05) between the 2 groups for the HR  LVDP product
(Figure 3, A).
Diastolic function. Because LVEDP was fixed at the
beginning of the perfusion, there was no difference between
the 2 groups during the hypoxic baseline period. At the end
of reoxygenation, LVEDP was lower (P .01) in normoxic
than in hypoxic hearts (Figure 3, B). CPP and coronary
vascular resistance were significantly higher (P  .001 and
P  .05, respectively) in normoxic hearts at the beginning
of the hypoxic stabilization, as well as at the end of reoxy-
genation (Figure 3, C).
TABLE 1. Blood and morphologic data in the animals at the end of the 2-week exposure to normoxic (oxygen saturation,
21%) or hypoxic (oxygen saturation, 10%) environment
Normoxia Chronic hypoxia P value
No. 9 9 NS
Initial body weight, g 249 5.3 237 5.1 NS
Hematocrit, % 40 6 69 6 .0001
Hemoglobin, g/L 124 12 219 14 .0001
Red blood cells/L/1000 6.32 0.5 10.30 0.6 .0001
Ingested food, g/d 30.7 3.9 22.3 4.8 .001
Ingested water, mL/d 50.4 14.6 21.0 3.1 .0001
Final body weight, g 351 40.1 182 14.2 .0001
Heart weight, mg 1312 128 1107 119 .005
Heart/body weight ratio, mg/g 3.74 0.1 6.10 0.8 .0001
Arterial PO2 mm Hg 58.7 5.1 34.1 1.1 .005
Arterial oxygen saturation, % 90.1 1.0 43.0 3.0 .001
Data are expressed as means  SD. NS, Not significant.
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Although, during the hypoxic baseline period, the venous
PO2 remained low in both groups, during reoxygenation, it
was higher in hypoxic hearts, showing a significantly (P 
.01) lower oxygen uptake in this group (Figure 4, A). During
hypoxic baseline lactate production, lactate turnover and
ATP turnover were higher in normoxic hearts (P  .0001,
P  .0001, and P  .005, respectively; Figure 4, B-D),
whereas during reoxygenation, lactate was undetectable in
both groups.
Discussion
Hypoxic states of the cardiovascular system, which are
associated with the most frequent diseases of modern times,
originate from the imbalance between the amount of oxygen
supplied to the cardiac cell and the amount required. The
degree of hypoxic injury depends not only on the intensity
and duration of the hypoxic stimulus but also on the cardiac
tolerance to oxygen deprivation. This variable changes sig-
nificantly during phylogenetic and ontogenetic develop-
ment. The heart of an adult poikilotherm is significantly
more resistant compared with that of the homeotherm. Sim-
ilarly, the immature homeothermic heart is more resistant
than the adult homeothermic heart, possibly as a conse-
quence of its greater capability for anaerobic glycolysis.
Children with cardiac malformations are often cyanotic,
and the surgical intervention for cyanotic congenital heart
defects is hindered by greater mortality and morbidity than
in the corresponding treatment in noncyanotic hearts.4,17 This
feature may arise from the injury induced by acute reoxy-
genation at the onset of cardiopulmonary bypass,13-16,19
with free radicals as a major mediator in the hypoxia-
reoxygenation injury.13,16
Despite the fact that the vast majority of experimental
studies, including ours,5-7 have evaluated the effects of
acute hypoxia on the cardiovascular system, within the last
few years, an increasing number of studies concerned
chronic hypoxia,8,9,11,12,20 and it is now evident that hyp-
oxia produces long-term effects that could profoundly in-
fluence the myocardial metabolism and function.3,8-12
To perform the functional and metabolic evaluation, we
used the conventional Langendorff model of the isolated
perfused heart, with its well-known advantages and limits.18
Recently, a very promising mathematic model to study the
cardiovascular effects of hypoxia has been presented and
validated.21
Animal Homeostasis
In this study exposure to normobaric chronic hypoxia in-
duced profound changes in the blood oxygen transport
characteristics. The selected FIO2 for chronic hypoxia would
yield a PaO2 of 45 mm Hg, which is equivalent to 5500 m
Figure 3. Time course of the HR  LVDP product (A), LVEDP (B), and coronary vascular resistance (C) during the
first 30 minutes of the hypoxic baseline period (oxygen saturation, 10%), followed by 30 minutes of reoxygenation
(oxygen saturation, 100%). A and C, *P < .05; B, *P < .01.
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above sea level and not substantially different from the PaO2
of most children with cyanotic congenital heart defects. The
increase in hematocrit values, hemoglobin concentration,
and red blood cell count, common findings in all experi-
mental and clinical studies with chronic hypoxia, is a well-
known consequence of increased hypoxia-induced erythro-
poietin production.20,22
Because all rats entered the protocol at 5 weeks of age,
normoxic rats experienced physiologic net weight gain over
2 weeks (102  13 g). Despite unlimited access to food
and water, hypoxia-induced deterioration was more power-
ful than the physiologic net weight gain in hypoxic rats,
which underwent weight loss (–55  9 g); this is similar to
the situation seen in adult human subjects exposed to high
altitude for variable periods and to that in children with
cyanotic congenital heart defects. The weight change did
not correlate with the amount of ingested food, indicating
greater efficiency in food consumption in normoxic than in
hypoxic animals.12
The higher ratio between heart weight and body weight
observed in hypoxic rats indicates ventricular hypertrophy,
probably as a result of hypoxia-induced expression of sev-
eral growth factors, including the vascular endothelial
growth factor, as well as of increased systemic and vascular
resistance caused by the higher hematocrit value.23
Myocardial Function
Although both systolic and diastolic functions were the
same in the 2 groups during the hypoxic baseline period, the
reoxygenation induced different behavior. The hearts from
hypoxic animals appear more vulnerable than normoxic
hearts to a sudden increase of oxygen supply after a short
period of oxygen shortage. Possibly the decreased ventric-
ular compliance and impaired contractility are due to the
hypoxia-induced calcium load, which is further increased
by the sudden reoxygenation. In this regard, we demon-
strated, in previous studies, the occurrence of reoxygenation
injury within the first few minutes of full oxygen readmis-
sion,15 as well as the possibility of reducing the reoxygen-
ation injury by reducing the rate of reoxygenation,14 as
routinely performed in our clinical practice.24
Reduced coronary vascular resistance in hypoxic hearts
during the hypoxic perfusion, as well as during the reoxy-
genation, shows that chronic hypoxia induces coronary va-
sodilation. The increased coronary flow with acute oxygen
shortage has already been reported.20 In our previous ex-
Figure 4. Metabolic parameters at the end of the hypoxic baseline period (oxygen saturation, 10%) with the values
for oxygen uptake (A), lactate production (B), lactate turnover (C), and ATP turnover (D). A, *P < .01, normoxia
versus chronic hypoxia; B and C, *P < .0001; D, *P < .005.
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perimental studies with acute hypoxia, the coronary blood
flow increased up to 600% of baseline values during the
period of oxygen shortage, with a value remaining higher
than that at baseline (200%), even during the entire period
of reoxygenation.25 The effect of coronary vasodilation with
hypoxia, probably mediated by nitric oxide release,9,23,26 in
the present model could have been exaggerated by the
sudden decrease of the viscosity of coronary perfusion,
which is more important in hypoxic polyglobulic than in
normoxic hearts, because of our use of crystalloid solution
for heart perfusion.
Myocardial Metabolism
During the hypoxic baseline period, hearts extracted all the
oxygen available, as from the very low venous PO2. Despite
a similar performance, hearts recruited their anaerobic ca-
pacities to a different extent. The contribution of anaerobic
mechanisms to total ATP turnover during the hypoxic base-
line period, which was higher in hypoxic than in normoxic
hearts, confirms that chronic hypoxia induces different de-
grees of hypoxic adaptation. In reoxygenated hearts lactate
release was virtually undetectable, and therefore we specu-
lated that hearts had to completely rely on aerobic metab-
olism. Lack of correlation between ATP turnover and per-
formance indicates that the efficiency of energy production
is different in the 2 groups because of increased activation
of the mitochondrial KATP channels, probably the result of
increased intracellular lactate,27 or because of mitochondrial
damage induced by reoxygenation.28 Our data confirm the
results of clinical studies on children with cyanotic congen-
ital heart defects showing a direct correlation between the
bioenergetics (ATP levels) and myocardial performance.4,17
Limits of the Model
One limit of our model is that animals entered the protocol
at 5 weeks of age, whereas children with cyanotic congen-
ital heart defects have generally been cyanotic since birth
and have never been exposed to normoxia. It is true that the
effect of normoxia for a certain period of time before
chronic hypoxia has not yet been clarified. Nevertheless, it
is well known to surgeons regularly involved with cyanotic
congenital heart defects that in clinical practice there are
examples of children with tetralogy of Fallot and with
congenital heart defects with ductus-dependent pulmonary
blood flow who are acyanotic at birth but become cyanotic
later in life in correspondence, respectively, of the first
hypoxic spell and of the ductal closure.
As a matter of fact, there are recent reports of experi-
mental studies with pregnant guinea pigs29 or rats30 exposed
to chronic hypoxia; unfortunately, the interpretation of the
results provided by these studies must take into account the
intermittent reoxygenation of the neonate animals when
exposed to room air for feeding and maintenance, which is
exactly what we wanted to avoid by creating our new
system of hypoxic cages.
Another limit is the type of chronic hypoxia with envi-
ronmental hypoxia. Other authors reported experimental
studies using surgical models to induce central cyanosis,
which is similar to the situation found with cyanotic chil-
dren.3,10,30 Certainly the surgical models used in dogs3,10 or
lambs31 are not reproducible in a rat model.
Conclusion
Our experimental model allows the evaluation of the nega-
tive systemic and cardiac effects of chronic hypoxia and the
myocardial impairment caused by uncontrolled reoxygen-
ation of hypoxic hearts. Alternative strategies of reoxygen-
ation at the beginning of cardiopulmonary bypass should be
considered for children with cyanotic congenital heart de-
fects.
We thank Dideco, Mirandola, Italy, for kindly providing us
with the micro-oxygenators used in this experimental study.
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